Some companies have trajectories that read like novels. Coty is one of them. Founded in 1904 in Paris by François Coty, the company navigated the 20th century, multiple ownership changes, a turbulent IPO, the $12 billion acquisition of P&G Beauty in 2016 — a deal that proved catastrophically mispriced — and a painful restructuring that is still ongoing.
But there’s a sign Coty may have understood something: its results in prestige fragrance are showing clear improvement. And that’s where the analysis gets interesting.
The transformation thesis
Coty’s strategy since 2020 rests on a simple idea: exit the mass-market cosmetics where margins are thin and competition is total, and move up toward prestige — fragrance and skincare — where Coty has distinctive assets and premium brand licenses.
Coty’s license portfolio is substantial: Burberry, Bottega Veneta, Calvin Klein, Chloé, Davidoff, Gucci (for beauty and fragrances), Hugo Boss, Marc Jacobs, and others. These licenses represent rights to use premium brand names in defined categories — fragrances, skincare, makeup depending on the brand.
The value of a license depends entirely on the ability to execute it. That’s where Coty has historically varied — for better and worse.
Fragrance as the pivot
Perfume is one of the beauty categories with the best economic fundamentals: high gross margins, low exposure to commodity inputs, strong repurchase rates once a consumer is loyal to a scent.
Prestige fragrance — fragrances sold in selective perfumeries and department stores at prices above €70-80 per bottle — has been the category with the most robust growth for several years. Consumers are seeking premium olfactory experiences, notably in niche (independent fragrances, confidential juices). Coty plays in the “accessible prestige” segment — not quite niche, but clearly above mass-market.
Recent results on Gucci Beauty, Burberry Beauty, and Hugo Boss Fragrances show positive momentum. Not extraordinary, but a workable foundation.
Celebrity licensing: the controversial segment
Coty has also developed a celebrity fragrance portfolio — Kylie Jenner, Kim Kardashian (via its equity stake in KKW), and others. This is a segment with an ambiguous reputation in the industry: potentially significant volumes, but image risks for the licensor and dependence on a celebrity’s fluctuating fame.
The bet has its reasons. These fragrances often sell well — fans buy, social media amplifies. But longevity is uncertain, and the reputational risk is real.
What remains to be done
Coty isn’t out of the woods. Debt remains significant. Deleveraging is one of the priorities the management has publicly stated. JAB Holding, the reference shareholder, has sold part of its stake — which can be read as normalization or as a caution signal.
What Coty has managed to demonstrate is that a restructuring around a clear thesis (prestige, fragrance, premium licenses) can stabilize a company and create a growth base. What comes next depends on brand execution, balance sheet management, and the ability to renew the license portfolio at reasonable terms.
This is a case where “less bad” and “progressing” must be distinguished from “transformed.” Coty is progressing. The transformation still needs to be confirmed.